US Patent 12077571 Polyomavirus neutralizing antibodies
Patent 12077571 was granted and assigned to Novartis on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+33 properties)
Article (+188 characters)
US Patent 12077571 Polyomavirus neutralizing antibodies
Article
Patent abstract
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Adam Lloyd Feire0
Danqing Wu0
Elisabetta Traggiai0
Fangmin Xu0
Johanna Abend0
Lichun Wang0
Mark Knapp0
Qilong Wu0
Steven Kovacs0
Yongqiang Wang0
Zorica Dragic0
Date of Patent
September 3, 2024
0Patent Application Number
181860640
Date Filed
March 17, 2023
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12077571 Polyomavirus neutralizing antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
